P. Callau

Observational cohort study of rilpivirine (RPV) utilization in Europe

C. Leen, A. Mocroft, R. Paredes, 2022, AIDS Research and Therapy.

Clinical characteristics, risk factors, and incidence of symptomatic coronavirus disease 2019 in a large cohort of adults living with HIV: a single-center, prospective observational study

Felipe García, J. Miro, J. Mallolas, 2020, AIDS.

Dynamics of creatinine estimated glomerular filtration rate using one or more antiretrovirals that inhibit creatinine tubular secretion.

E. Negredo, E. Martinez, J. De La Torre, 2021, The Journal of antimicrobial chemotherapy.

Dolutegravir-based maintenance monotherapy versus dual therapy with lamivudine: a planned 24 week analysis of the DOLAM randomized clinical trial

Roger Paredes, Esteban Martinez, Bonaventura Clotet, 2018, The Journal of antimicrobial chemotherapy.

Impact of an enhanced screening program on the detection of non-AIDS neoplasias in patients with human immunodeficiency virus infection

D. Podzamczer, J. Mallolas, J. Losa, 2021, Trials.

Factors associated with the number of drugs in darunavir/cobicistat regimens.

E. Negredo, E. Ribera, M. Pérez-Elías, 2019, The Journal of antimicrobial chemotherapy.

Outcomes by sex following treatment initiation with darunavir/cobicistat in a large Spanish cohort of the CODAR study (GeSIDA 9316).

J. M. García de Lomas, J. De La Torre, E. Ribera, 2019, The Journal of antimicrobial chemotherapy.

Inflammatory Bowel Disease Is an Independent Risk Factor for Metabolic Dysfunction-Associated Steatotic Liver Disease in Lean Individuals.

J. Ampuero, F. Gomollón, S. J. Martínez-Domínguez, 2023, Inflammatory bowel diseases.

Crohn´s disease is an independent risk factor for liver fibrosis in patients with inflammatory bowel disease and non-alcoholic fatty liver disease.

S. J. Martínez-Domínguez, M. T. Arroyo-Villarino, C. Gargallo-Puyuelo, 2023, European journal of internal medicine.

Impact of an enhanced screening program on the detection of non-AIDS neoplasias in patients with human immunodeficiency virus infection

D. Podzamczer, J. Mallolas, J. Losa, 2021, Trials.